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Introduction 
 
Cell volume regulation is a property present in most animal cell lineages that allows them 
to recover their original volume after events of swelling or shrinkage. Such events can be 
caused by changes in external osmolarity or to osmotic gradients generated during normal 
cell functioning.4,6 The mechanism of cell volume regulation involves transmembrane 
fluxes of osmotically active solutes in the necessary direction to counteract the net gain or 
loss of intracellular water.9 The process through which cells recover their normal volume 
after swelling is named Regulatory Volume Decrease (RVD). This consists of the efflux of 
inorganic osmolytes, such as K+ and Cl–, as well as organic compounds such as free amino 
acids, methyl amines, and polyalcohols. These movements create a new osmotic gradient 
that leads to water efflux and volume recovery. 
The simplest and more often experimental paradigm used in RVD studies consists of 
sudden exposures of cells/tissues to mild-to-acute hyposmotic media (~20 to 50% hy-
posmotic) and recording different cell parameters (cell volume, osmolyte release, mem-
brane potential, conductances, etc.) These conditions, however, do not occur under normal, 
physiological circumstances, where changes in external or internal osmolarity are gradual, 
as the different homeostatic systems are challenged and activated.12 Even in pathological 
situations, such as water intoxication or hyponatremia, the activation and eventual surpas-
sing of the encephalic mechanisms of water and electrolyte control lead to progressive os-
motic changes in the extracellular brain milieu.3 
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Gradual and continuous changes in external osmolarity (in contrast to the sudden 
changes usually used) were introduced by Lohr and Grantham8 to examine volume regu-
lation properties in the S2 proximal tubules. It was observed that regardless of the progres-
sive reduction in the osmolarity medium cells do not swell, provided that the rate of change 
does not exceed –3.0 mOsmol/min. The adaptive cell response occurred, however, as cells 
swell immediately after reintroduction of isosmotic medium.8 The response was described 
as Isovolumic Regulation due to the lack of change in cell volume. In the present study, we 
described the occurrence of Isovolumic Regulation in different preparations of nervous 
tissue, where it is observed, the early activation of taurine and glutamic acid efflux, as well 
as the relatively late (or absence of) mobilization of K+. 
 
Results and Discussion 
 
Although the experimental model of large and sudden decreases in osmolarity had ren-
dered valuable information to elucidate some basic mechanisms of cell volume control, 
such changes probably never occur in the brain under physiological conditions. This is also 
true during pathological situations such as chronic hyponatremia, water intoxication, or 
the inappropriate secretion of vasopressin, when the osmolarity changes in the brain inter-
stitial space occurs most likely in a gradual manner, as the osmotic challenge from plasma 
progressively surpasses the brain homeostatic resistance.3,12 Thus, the experimental ap-
proach of the present work, decreasing gradually and slowly the external osmolarity, 
could reflect more accurately physiological variations. Under these conditions, figure 1 
shows the lack of change in cell volume when hippocampal slices (A) or cultivated neu-
rones (B) are exposed to the osmotic gradient, regardless of the low, final external osmo-
larity (~150 mOsmol/l or 50% hyposmotic ). This constancy in cell volume appears to result 
from an active process of volume control accomplished by the adjustment of osmolyte in-
tracellular content and its named Isovolumic Regulation (IVR). This is supported by the 
swelling observed in cells previously exposed to gradual hyposmotic changes and sud-
denly returned to isosmotic medium.8 
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Figure 1. Cell volume changes of hippocampal slices and cerebellar granule neurones ex-
posed to a continuous hyposmotic gradient (300 mOsmol/l ⇒ 150 mOsmol/l). A gradient-
generating system was constructed as described by Van Driessche et al.13 The rate of 
change in osmolarity was adjusted at –2.5 or –1 .8 mOsmol/min for the experiments with 
hippocampal slices or cell cultures, respectively. A and B: At time 0 in figures, slices or 
cerebellar granule neurones were superfused with the osmotic gradient and cell volume 
was determined at different times. A. Volume changes in hippocampal slices were indi-
rectly estimated by quantification of tissue water content corrected by the interstitial space 
measured by 14C-inulin distribution. B. Relative cell volume in cerebellar granule neu-
rones was quantified fluorometrically, using calcein-AM as fluorescent dye.1 Data are 
means ± SE of 6 (A) or 3 (B) individual experiments. 
 
Figure 2 shows the efflux of 3H-taurine and 3H-D-aspartate from hippocampal slices (A), 
cerebellar granule neurones (B), or cerebellar astrocytes (C) elicited by a continuous hy-
posmotic gradient (300 ⇒ 150 mOsmol/l). In these preparations it is observed first, that 
efflux of both amino acids is activated early during IVR; second, the lower the external 
osmolarity is, the faster the amino acid efflux, showing no inactivation phase; third, the 
release of taurine is larger than that of D-aspartate. A similar higher efflux rate for taurine 
as compared with other osmolytes has been observed in rat brain in vivo upon microdial-
ysis perfusion with hyposmotic solutions.2,11 
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Figure 2. Amino acid efflux from hippocampal slices, cerebellar granule neurones, and 
cerebellar astrocytes elicited by a continuous hyposmotic gradient. Preloaded tissues 
were initially superfused with isosmotic medium (6–10 min) and then (at arrow) exposed 
to the osmotic gradient (300 ⇒ 150 mOsmol/l). (): 3H-taurine; (●): 3H-D-aspartate in all 
figures. Data are expressed as efflux rate constants and are means ± SE of 6 (A), 8 (B), or 2 
(C) individual experiments. 
 
In the present study, the release of taurine and D-aspartate during IVR were resolved 
into three first-order velocity components by fitting linear regressions to different seg-
ments of the efflux curves. Table 1 shows the derived kinetic constants for hippocampal 
slices and cerebellar granule neurones, along with the corresponding external osmolarity 
ranges. The osmotic intervals for each of the release components of taurine and D-aspartate 
are remarkably similar, suggesting a common efflux pathway. 
 
Table 1. Kinetic constants of 3H-taurine and 3H-D-aspartate fluxes from cerebellar granule neu-
rones and hippocampal slices elicited by a continuous hyposmotic gradient 
Cerebellar Granule Neurones k1(x10–5) k2(x10–5) k3(x10–5) 
External osmolarity range (mOsmol/l) 300  249 248  203 202  156 
3H-D-Aspartate N.A. 10.37 ± 0.53 37.17± 1.26 
3H-Taurine 5.29 ± 0.33 34.97 ± 1.59 213.38 ± 10.12 
Hippocampal Slices k1(xl0–5) k2(x10–5) k3(xl0–5) 
External osmolarity range (mOsmol/l) 300  250 249  178 175  150 
3H-D-Aspartate –2.322 ± 0.111 2.070 ± 0.219 7.138 ± 1.070 
3H-Taurine –4.066 ± 0.542 8.968 ± 0.502 34.829 ± 3.733 
The efflux of 3H-taurine and 3H-aspartate under IVR conditions were kinetically analyzed adjusting the ex-
perimental data of figure 1 to lineal regressions in different segments of the curves, as indicated (fractions). 
Values are the slopes of the adjusted averaged points ± S.E. (n= 4–8) N.A.: Not adjusted 
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Moreover, such intervals are similar also between preparations, i.e. k1 describe taurine 
and D-aspartate fluxes during the same osmotic range in hippocampal slices and granule 
neurones. This suggests that the efflux mechanisms present in both preparations have sim-
ilar osmotic sensitivities. The magnitude of the rate release for each amino acid, however, 
is notably different. In the hippocampal slices, k1 for taurine is about half of that of D-
aspartate (table 1). When the amino acids efflux is described by k2 and k3, velocity of taurine 
efflux is 4 times higher than that of D-aspartate. Similar differences are observed in cere-
bellar granule neurones: k2 and k3 for taurine efflux are about 3.5 and 5.7 times higher than 
those of D-aspartate. These differences could be due to distinct permeability coefficients 
through the suggested common pathway, or/and to different availabilities of the intracel-
lular pools. Brain glutamate is extremely active and deeply involved in synaptic transmis-
sion and thus is sequestered into vesicles and other metabolic compartments. Taurine in 
contrast, is essentially an inert compound, not contributing to protein synthesis nor in-
volved in any metabolic reaction, and is found essentially free in the cytosol.5 All these 
results suggest a predominant role for taurine in volume regulation in brain. 
Potassium is an important osmolyte due to its high intracellular content. An osmosen-
sitive release of K+ has been consistently described in cells showing regulatory volume de-
crease (RVD).6,9 In cerebellar astrocytes, it has been shown that K+ efflux is the rate-limiting 
factor in an ongoing RVD process.10 In isovolumic conditions, an osmosensitive K+ outflow 
has been clearly shown in renal cells. In the distal nephron cell line A6, K+ efflux is activated 
with a threshold13 of 210 mOsmol/l, while in renal proximal tubules K+ content decreased 
after superfusion with an osmotic gradient.7 Figure 3 shows the release of K+ (traced with 
86Rb) during IVR, from hippocampal slices (A) and cerebellar granule neurones (B). In this 
last preparation, K+ outflow initially follows a k1 equal to 4.98 ± 0.36 x10–5 until the external 
osmolarity has decreased 90 mOsmol (≈ 30% hyposmotic). This value is in the same range 
as that measured in isosmotic conditions (3.48 ± 0.15 x 10–5). When the external osmolarity 
has decreased ≈ 65 mOsmol, K+ efflux is activated and its movement follows a second k, 
with a value of 39.97 ± 1.04 × l0–5 for the rest of the experiment. In contrast, 86Rb outflow 
from hippocampal slices does not change during IVR, and its efflux runs parallel with that 
observed under isosmotic conditions. This is an unexpected result, since as previously 
mentioned, K+ is a key osmolyte in essentially all cell types. The difference in K+ efflux 
during RVD and IVR may be due to the involvement, in each case, of different mechanisms 
of release. In renal proximal tubules, the Na+-K+ ATPase seems implicated in IVR7 but not 
in RVD. Also, these two processes differ in A6 cells13 . In addition, unlike in cells in culture, 
in the hippocampal slices which have an intact cytoarchitecture, buffering of extracellular 
K+ by the efficient mechanisms known to exist in brain tissue, could mask an osmosensitive 
release occurring gradually as during IVR. Due to the key role played by K+ in nervous 
excitability, its extracellular levels in brain have to be kept under strict control. Clearly, 
studies on the occurrence and features of IVR in different cell types are essential for a better 
understanding of the physiological significance of this mechanism of volume regulation. 
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Figure 3. 86Rb efflux from hippocampal slices and cerebellar granule neurones elicited by 
a continuous hyposmotic gradient. Preloaded tissues were initially superfused with isos-
motic medium (6–10 min) and then (at arrow) exposed to the osmotic gradient (300 
mOsmol/l ⇒ 150 mOsmol/l). A and B (●): Hyposmotic gradient; B (): Isosmotic medium. 
Data are expressed as efflux rate constants and are means ± SE of 6 (A) or 8 (B) individual 
experiments. 
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